These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33902187)
1. [Metabolic-associated fatty liver disease-related liver cirrhosis and cryptogenic liver cirrhosis]. Song Y; Shi JP Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):213-215. PubMed ID: 33902187 [TBL] [Abstract][Full Text] [Related]
2. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study. Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085 [TBL] [Abstract][Full Text] [Related]
4. Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma. Xie X; Zheng M; Guo W; Zhou Y; Xiang Z; Li Y; Yang J Sci Rep; 2022 Aug; 12(1):13969. PubMed ID: 35978032 [TBL] [Abstract][Full Text] [Related]
5. NASH and HCC. Page JM; Harrison SA Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310 [TBL] [Abstract][Full Text] [Related]
6. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis. Amarapurkar DN; Dharod M; Gautam S; Patel N Trop Gastroenterol; 2013; 34(3):159-63. PubMed ID: 24851525 [TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease. Yang NB; Li GX; Chu JG; Wang YJ Hepatology; 2020 Jun; 71(6):2172-2173. PubMed ID: 31849080 [No Abstract] [Full Text] [Related]
9. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468 [TBL] [Abstract][Full Text] [Related]
10. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781 [TBL] [Abstract][Full Text] [Related]
11. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Nair S; Mason A; Eason J; Loss G; Perrillo RP Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359 [TBL] [Abstract][Full Text] [Related]
13. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554 [TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease. Tantai X; Liu N; Wang J Hepatology; 2020 Jul; 72(1):363-364. PubMed ID: 31904864 [No Abstract] [Full Text] [Related]
15. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis. Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756 [TBL] [Abstract][Full Text] [Related]
16. [Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years]. Tsutsumi K; Nakayama H; Sakai Y; Kojima Y; Dairaku N; Ojima T; Kusano M; Ikeya S; Sugai Y; Hiwatashi N Nihon Shokakibyo Gakkai Zasshi; 2007 May; 104(5):690-7. PubMed ID: 17485950 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. Dhamija E; Paul SB; Kedia S Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369 [TBL] [Abstract][Full Text] [Related]
18. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?]. Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567 [TBL] [Abstract][Full Text] [Related]